Trial Profile
Safety and efficacy study of Deferasirox in patients with sickle cell for the management of transfusion related iron overload
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Dec 2015
Price :
$35
*
At a glance
- Drugs Deferasirox (Primary)
- Indications Sickle cell anaemia
- Focus Adverse reactions; Therapeutic Use
- 14 Dec 2015 New trial record